Upgrade to SI Premium - Free Trial

Morgan Stanley Makes Bullish Call on Valeant (VRX); Rating Raised to 'Overweight'

August 17, 2016 6:59 AM
(Updated - August 17, 2016 10:46 AM EDT)Morgan Stanley upgraded Valeant Pharmaceuticals (NYSE: VRX) from Equalweight to Overweight with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Hot Upgrades Momentum Movers Short Sales Upgrades

Next Articles